Delucemina (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Delucemina" in Spanish language version.

refsWebsite

Global rank Spanish rank

7doi.org

2^nd place

3issn.org

57^th place

3^rd place

3nih.gov

4^th place

1secdatabase.com

4,147^th place

7,678^th place

1books.google.com

3^rd place

7^th place

1ncats.io

low place

1medkoo.com

low place

books.google.com (Global: 3^rd place; Spanish: 7^th place)

Nentwig, Wolfgang (15 de febrero de 2013). Spider Ecophysiology. Springer Science & Business Media. ISBN 9783642339899.

doi.org (Global: 2^nd place; Spanish: 2^nd place)

dx.doi.org

Monge-Fuentes, Victoria; Gomes, Flávia Maria Medeiros; Campos, Gabriel Avohay Alves; Silva, Juliana de Castro; Biolchi, Andréia Mayer; dos Anjos, Lilian Carneiro; Gonçalves, Jacqueline Coimbra; Lopes, Kamila Soares et al. (8 de agosto de 2015). «Neuroactive compounds obtained from arthropod venoms as new therapeutic platforms for the treatment of neurological disorders». Journal of Venomous Animals and Toxins including Tropical Diseases 21 (1). ISSN 1678-9199. doi:10.1186/s40409-015-0031-x. Consultado el 5 de mayo de 2023.
Yaari, Roy; Kumar, Shubha; Tariot, Pierre N (23 de junio de 2008). «Non-cholinergic drug development for Alzheimer's disease». Expert Opinion on Drug Discovery 3 (7): 745-760. ISSN 1746-0441. doi:10.1517/17460441.3.7.745. Consultado el 5 de mayo de 2023.
Mueller AL, Artman LD, Balandrin MF, Brady E, Chien Y, Delmar EG, George K, Kierstead A, Marriott TB, Moe ST, Newman MK, Raszkiewicz JL, Sanguinetti EL, van Wagenen BC, Wells D (December 1999). «NPS 1506, a novel NMDA receptor antagonist and neuroprotectant. Review of preclinical and clinical studies». Annals of the New York Academy of Sciences 890: 450-7. PMID 10668449. doi:10.1111/j.1749-6632.1999.tb08023.x.
Leoni MJ, Chen XH, Mueller AL, Cheney J, McIntosh TK, Smith DH (December 2000). «NPS 1506 attenuates cognitive dysfunction and hippocampal neuron death following brain trauma in the rat». Experimental Neurology 166 (2): 442-9. PMID 11085909. doi:10.1006/exnr.2000.7513.
Pałasz, Artur; Krzystanek, Marek (25 de septiembre de 2021). «Spider Neurotoxins as Modulators of NMDA Receptor Signaling». NeuroMolecular Medicine 24 (3): 250-256. ISSN 1535-1084. doi:10.1007/s12017-021-08692-w. Consultado el 5 de mayo de 2023.
«Spider Venom Components as Drug Candidates». Spider Ecophysiology. February 2013. pp. 491-503. ISBN 978-3-642-33988-2. doi:10.1007/978-3-642-33989-9_37.
Monge-Fuentes V, Gomes FM, Campos GA, ((Silva Jd)), Biolchi AM, Dos Anjos LC, Gonçalves JC, Lopes KS, Mortari MR (August 2015). «Neuroactive compounds obtained from arthropod venoms as new therapeutic platforms for the treatment of neurological disorders». The Journal of Venomous Animals and Toxins Including Tropical Diseases 21 (31): 31. PMC 4529710. PMID 26257776. doi:10.1186/s40409-015-0031-x.

issn.org (Global: 57^th place; Spanish: 3^rd place)

portal.issn.org

Monge-Fuentes, Victoria; Gomes, Flávia Maria Medeiros; Campos, Gabriel Avohay Alves; Silva, Juliana de Castro; Biolchi, Andréia Mayer; dos Anjos, Lilian Carneiro; Gonçalves, Jacqueline Coimbra; Lopes, Kamila Soares et al. (8 de agosto de 2015). «Neuroactive compounds obtained from arthropod venoms as new therapeutic platforms for the treatment of neurological disorders». Journal of Venomous Animals and Toxins including Tropical Diseases 21 (1). ISSN 1678-9199. doi:10.1186/s40409-015-0031-x. Consultado el 5 de mayo de 2023.
Yaari, Roy; Kumar, Shubha; Tariot, Pierre N (23 de junio de 2008). «Non-cholinergic drug development for Alzheimer's disease». Expert Opinion on Drug Discovery 3 (7): 745-760. ISSN 1746-0441. doi:10.1517/17460441.3.7.745. Consultado el 5 de mayo de 2023.
Pałasz, Artur; Krzystanek, Marek (25 de septiembre de 2021). «Spider Neurotoxins as Modulators of NMDA Receptor Signaling». NeuroMolecular Medicine 24 (3): 250-256. ISSN 1535-1084. doi:10.1007/s12017-021-08692-w. Consultado el 5 de mayo de 2023.

medkoo.com (Global: low place; Spanish: low place)

«Delucemine Hydrochloride | NPS-1506 | CAS#186495-99-8 | CAS#186495-49-8 | Glutamate Receptor Antagonist | MedKoo». www.medkoo.com. Consultado el 5 de mayo de 2023.

ncats.io (Global: low place; Spanish: low place)

drugs.ncats.io

«NCATS Inxight Drugs — DELUCEMINE». drugs.ncats.io (en inglés). Consultado el 5 de mayo de 2023.

nih.gov (Global: 4^th place; Spanish: 4^th place)

ncbi.nlm.nih.gov

Mueller AL, Artman LD, Balandrin MF, Brady E, Chien Y, Delmar EG, George K, Kierstead A, Marriott TB, Moe ST, Newman MK, Raszkiewicz JL, Sanguinetti EL, van Wagenen BC, Wells D (December 1999). «NPS 1506, a novel NMDA receptor antagonist and neuroprotectant. Review of preclinical and clinical studies». Annals of the New York Academy of Sciences 890: 450-7. PMID 10668449. doi:10.1111/j.1749-6632.1999.tb08023.x.
Leoni MJ, Chen XH, Mueller AL, Cheney J, McIntosh TK, Smith DH (December 2000). «NPS 1506 attenuates cognitive dysfunction and hippocampal neuron death following brain trauma in the rat». Experimental Neurology 166 (2): 442-9. PMID 11085909. doi:10.1006/exnr.2000.7513.
Monge-Fuentes V, Gomes FM, Campos GA, ((Silva Jd)), Biolchi AM, Dos Anjos LC, Gonçalves JC, Lopes KS, Mortari MR (August 2015). «Neuroactive compounds obtained from arthropod venoms as new therapeutic platforms for the treatment of neurological disorders». The Journal of Venomous Animals and Toxins Including Tropical Diseases 21 (31): 31. PMC 4529710. PMID 26257776. doi:10.1186/s40409-015-0031-x.

secdatabase.com (Global: 4,147^th place; Spanish: 7,678^th place)

edgar.secdatabase.com

«NPS Pharmaceuticals Inc, Form 10-Q, Quarterly Report, Filing Date May 17, 2004». secdatabase.com. Consultado el 14 de mayo de 2018.